Ignite Creation Date:
2025-12-25 @ 2:20 AM
Ignite Modification Date:
2025-12-27 @ 11:03 PM
Study NCT ID:
NCT06210334
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-02-20
First Post:
2024-01-02
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
HAIC Combine Tislelizumab and Lenvatinib in the Treatment of HCC With Type IV (Vp4) Portal Vein Tumor Thrombus (HAI-TL)
Sponsor:
Li Xiao Wei
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-03
Start Date Type:
ESTIMATED
Primary Completion Date:
2025-07
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-01
Completion Date Type:
ESTIMATED
First Submit Date:
2024-01-02
First Submit QC Date:
None
Study First Post Date:
2024-01-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-02-17
Last Update Post Date:
2024-02-20
Last Update Post Date Type:
ACTUAL